Works matching IS 19307381 AND DT 2025 AND VI 33 AND IP 3


Results: 18
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis.

    Published in:
    Obesity (19307381), 2025, v. 33, n. 3, p. 522, doi. 10.1002/oby.24224
    By:
    • Al Dow, Manal;
    • Secco, Blandine;
    • Mouchiroud, Mathilde;
    • Rochette, Marianne;
    • Gilio, Gustavo R.;
    • Massicard, Mickael;
    • Hardy, Marilou;
    • Gélinas, Yves;
    • Festuccia, William T.;
    • Morissette, Mathieu C.;
    • Manem, Venkata S. K.;
    • Laplante, Mathieu
    Publication type:
    Article
    12
    13

    Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.

    Published in:
    Obesity (19307381), 2025, v. 33, n. 3, p. 452, doi. 10.1002/oby.24222
    By:
    • Kushner, Robert F.;
    • Ryan, Donna H.;
    • Deanfield, John;
    • Kokkinos, Alexander;
    • Cercato, Cintia;
    • Wilding, John;
    • Burguera, Bartolome;
    • Wu, Chau‐Chung;
    • Craciun, Anca‐Elena;
    • Pall, Denes;
    • Hramiak, Irene;
    • Hjelmesæth, Jøran;
    • Harder‐Lauridsen, Nina M.;
    • Weimers, Petra;
    • Jeppesen, Ole Kleist;
    • Kallenbach, Klaus;
    • Lincoff, A. Michael;
    • Lingvay, Ildiko
    Publication type:
    Article
    14
    15
    16
    17
    18

    Issue Information.

    Published in:
    Obesity (19307381), 2025, v. 33, n. 3, p. 425, doi. 10.1002/oby.23819
    Publication type:
    Article